2020
DOI: 10.36660/abc.20200273
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID -19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
14

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(20 citation statements)
references
References 47 publications
(49 reference statements)
0
6
0
14
Order By: Relevance
“…All the articles were developed with adult and aged patients diagnosed with COVID-19, with pre-existing CVDs; however, the development of heart failure was predominantly related to the advanced age profile of the patients under study (15,28,32). It was also verified that the left ventricular ejection fraction of less than 40%, at echocardiographic examination in cases of heart failure, combined with elevated serum troponin I and elevated ST segment at electrocardiographic examination, favor the worsening of COVID-19 patients' prognoses (36,(38)(39)(40).…”
Section: Discussionmentioning
confidence: 86%
See 2 more Smart Citations
“…All the articles were developed with adult and aged patients diagnosed with COVID-19, with pre-existing CVDs; however, the development of heart failure was predominantly related to the advanced age profile of the patients under study (15,28,32). It was also verified that the left ventricular ejection fraction of less than 40%, at echocardiographic examination in cases of heart failure, combined with elevated serum troponin I and elevated ST segment at electrocardiographic examination, favor the worsening of COVID-19 patients' prognoses (36,(38)(39)(40).…”
Section: Discussionmentioning
confidence: 86%
“…All the selected studies (1, 2, 8, 13-17, 28-34) for the final sample of this review brought coronary obstructive events as the main cardiac complication evidenced during hospitalization of patients with COVID-19. The obstructive events predominantly represented by acute myocardial infarction are possibly the result of an increased myocardial workload during infections, which cause myocardial injuries (37,(38)(39)(40). In addition, Sars-CoV-2 has been shown to trigger an exaggerated systemic inflammatory response, which, in addition to acute lung injury and acute respiratory distress syndrome, can lead to multiple cardiovascular complications (32,34), unstable angina, tachycardia, heart failure, stroke, cardiogenic shock and even cardiopulmonary arrest (37,39).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A r e l a ç ã o d a C O V I D -1 9 c o m o comprome mento do olfato é determinada pela anosmiapós-viral com lesão inflamatória do neuroepitélio olfatório ou devido a um bloqueio inflamatório das fendas olfatórias condu vas (SEPULVEDA et al, 2020). Essa conjuntura está associada ao vírus ligar-se à ECA-2, encontrada principalmente nas vias respiratórias (ASKIN et al, 2020).…”
Section: Desenvolvimentounclassified
“…This was even more pronounced among patients with a BMI of 35 years and above ( Lighter et al 2020 ). Cardiovascular disease was a common comorbidity among people infected with SARS and MERS ( Askin et al 2020 ). A review of six studies including 1527 patients with COVID-19 (mainly from Wuhan) found that the most prevalent cardiovascular comorbidities were hypertension (17.1 %) and cardia-cerebrovascular disease (16.4%) followed by diabetes (9.7%) ( Li et al 2020 ).…”
Section: Introductionmentioning
confidence: 99%